AIM ImmunoTech Inc. - stock earnings
AIM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -3.7 million USD | 49000 USD |
| 2022Q3 | -6.4 million USD | 21000 USD |
| 2022Q2 | -4.9 million USD | 30000 USD |
| 2022Q1 | -3.8 million USD | 33000 USD |
| 2021Q4 | -5.8 million USD | 50000 USD |
| 2021Q3 | -3.8 million USD | 33000 USD |
| 2021Q2 | -5.9 million USD | 23000 USD |
| 2021Q1 | -3.6 million USD | 28000 USD |
| 2020Q4 | -3.9 million USD | 42000 USD |
| 2020Q3 | -3.3 million USD | 36000 USD |
AIM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.1 million USD | 141000 USD |
| 2022 | -21.5 million USD | 135000 USD |
| 2021 | -16.3 million USD | 163000 USD |
| 2020 | -10.8 million USD | 140000 USD |
| 2019 | -9.8 million USD | 367000 USD |
| 2018 | -8.3 million USD | 437000 USD |
| 2017 | -7.5 million USD | 92000 USD |
| 2016 | -15.2 million USD | 133000 USD |
| 2015 | -17.5 million USD | 197000 USD |
| 2014 | -16.2 million USD | 150000 USD |
| 2013 | -17.4 million USD | 213000 USD |
| 2012 | -9.0 million USD | 161000 USD |
| 2011 | -13.1 million USD | 135000 USD |
| 2010 | -13.4 million USD | 111000 USD |
| 2009 | -12.2 million USD | 265000 USD |
| 2008 | -18.1 million USD | 1.1 million USD |
| 2007 | -19.4 million USD | 933000 USD |
| 2006 | -13.2 million USD | 1.1 million USD |
| 2005 | -24.1 million USD | 1.2 million USD |
| 2004 | -14.8 million USD | 657000 USD |
| 2003 | -7.4 million USD | 341000 USD |
| 2002 | -9.1 million USD | 390000 USD |
| 2001 | -8.6 million USD | 788000 USD |
| 2000 | -9.2 million USD | 700000 USD |
| 1999 | -7.3 million USD | 400000 USD |
| 1998 | -6.1 million USD | 300000 USD |
| 1997 | -4.6 million USD | 100000 USD |
| 1996 | -1.8 million USD | 3.0 million USD |
AIM
Price: $0.43
52 week price:
Earnings Per Share: -0.43 USD
P/E Ratio: -0.91
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 36383
Market Capitalization: 23.3 million